Registry of patients that have received the Caris Target Now and/or hematopoietic diagnostic testing

Active:	Yes
Cancer Type:	Multiple Primaries	NCT ID:	Caris
Trial Phases:		Protocol IDs:	Caris (primary)
Eligibility:	Patients who previously have undergone Caris Targe, Male and Female	Study Type:	Diagnostic
Study Sponsor:	Caris Life Sciences
NCI Full Details:

Summary

"A Registry of Caris Target Now^™ Test Results (Biomarker Expression Patterns) for Evaluation of Correlation with Clinical Outcomes for Cancer and other Patients" is a multi-center, observational outcomes database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, and outcomes of eligible patients who previously have undergone Caris Target Now testing for treatment of solid tumor cancer.

Objectives

The registry is a mechanism by which eligible patients can choose to participate through their physicians in cancer research. By contributing patients' data, physicians and patients gain the knowledge that future patients with similar disease profiles may benefit from the experiences of the patients that contributed information before them.

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.